Compartir
Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall (en Inglés)
Andreas Sashegyi (Editor), James Felli (Editor), Rebecca Noel (Editor) (Autor)
·
Crc Pr Inc
· Tapa Blanda
Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall (en Inglés) - Andreas Sashegyi (Editor), James Felli (Editor), Rebecca Noel (Editor)
Libro Nuevo
Importado
Envío: 12 a 14 días háb.
₡ 28.686
Costos de importación y 13% IVA incluídos en el precio ✅
Reseña del libro "Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall (en Inglés)"
Many practitioners in the pharmaceutical industry are still largely unfamiliar with benefit-risk assessment, despite its growing prominence in drug development and commercialization. Helping to alleviate this knowledge gap, Benefit-Risk Assessment in Pharmaceutical Research and Development provides a succinct overview of the key considerations relevant to benefit-risk assessment across the pharmaceutical R&D spectrum, from early clinical development to late-stage development to regulatory review to post-launch assessment.The book first presents interpretations of benefit and risk in the context of a molecule moving from preclinical evaluation into its early testing in humans. It next considers benefit and risk characterization and assessment during a molecule's journey from its clinical evaluation in humans through its submission to regulators for marketing approval. Throughout these sections, the book offers insight into the role of benefit-risk assessment in heightening understanding among key stakeholders by shaping questions and guiding discussions among scientists, physicians, developers, and regulatory agencies. The book also focuses on a molecule's entry into the marketplace as a drug available for consumption by people. It explores the role of benefit-risk assessment as the relevance of carefully collected clinical efficacy and safety metrics fades in the wake of real-world use and evidence of effectiveness and safety.Bringing together the expertise of 15 contributors from academia and the industry, this book offers an easy-to-read guide to the various facets of benefit-risk assessment in the major stages of pharmaceutical R&D. Suitable for those in both technical and managerial roles, it enables readers to communicate more effectively across their development chain as well as rationally and thoughtfully embed benefit-risk assessment into their R&D processes.
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
Todos los libros de nuestro catálogo son Originales.
El libro está escrito en Inglés.
La encuadernación de esta edición es Tapa Blanda.
✓ Producto agregado correctamente al carro, Ir a Pagar.
